[
  {
    "ts": null,
    "headline": "Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally.",
    "url": "https://finnhub.io/api/news?id=9d5e06a085080fb3b8e9198b14910f813ca9bbda614fe6d0e6d1f2808e4560b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753299351,
      "headline": "Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know",
      "id": 136062463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "OMC",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally.",
      "url": "https://finnhub.io/api/news?id=9d5e06a085080fb3b8e9198b14910f813ca9bbda614fe6d0e6d1f2808e4560b7"
    }
  },
  {
    "ts": null,
    "headline": "Avalere Health welcomes Rhiannon Meaden, Ph.D., as Head of Medical Strategy and Business Transformation",
    "summary": "Avalere Health, a global strategic partner for the healthcare industry, names Rhiannon Meaden, Ph.D., as its new Head of Medical Strategy and Transformation.",
    "url": "https://finnhub.io/api/news?id=73c6c636ef0c3e2f64adf475d4efdf33c46ee595b81253b308aeb5d09e6c15e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753275900,
      "headline": "Avalere Health welcomes Rhiannon Meaden, Ph.D., as Head of Medical Strategy and Business Transformation",
      "id": 136044597,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "OMC",
      "source": "Yahoo",
      "summary": "Avalere Health, a global strategic partner for the healthcare industry, names Rhiannon Meaden, Ph.D., as its new Head of Medical Strategy and Transformation.",
      "url": "https://finnhub.io/api/news?id=73c6c636ef0c3e2f64adf475d4efdf33c46ee595b81253b308aeb5d09e6c15e9"
    }
  },
  {
    "ts": null,
    "headline": "Omnicom Group: 4% Dividend Yield, AI Focus, Significant Upside Potential Make Them A Buy",
    "summary": "Omnicom Group: 4% Dividend Yield, AI Focus, Significant Upside Potential Make Them A Buy",
    "url": "https://finnhub.io/api/news?id=289296b95582474a3bf75b1c685f950b19f6f0b6c93230ab5efe50318da90b6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753258500,
      "headline": "Omnicom Group: 4% Dividend Yield, AI Focus, Significant Upside Potential Make Them A Buy",
      "id": 136040972,
      "image": "",
      "related": "OMC",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=289296b95582474a3bf75b1c685f950b19f6f0b6c93230ab5efe50318da90b6d"
    }
  },
  {
    "ts": null,
    "headline": "IPG Q2 Deep Dive: Strategic Transformation and Omnicom Deal Shape Outlook",
    "summary": "Global advertising conglomerate Interpublic Group (NYSE:IPG) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 6.6% year on year to $2.17 billion. Its non-GAAP profit of $0.75 per share was 33.7% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=91851b2c22fc7e5de5a94cc66dc5a7b4c18fa06fea9cf33a76df4ddf22a9808e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753248803,
      "headline": "IPG Q2 Deep Dive: Strategic Transformation and Omnicom Deal Shape Outlook",
      "id": 136039789,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "OMC",
      "source": "Yahoo",
      "summary": "Global advertising conglomerate Interpublic Group (NYSE:IPG) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 6.6% year on year to $2.17 billion. Its non-GAAP profit of $0.75 per share was 33.7% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=91851b2c22fc7e5de5a94cc66dc5a7b4c18fa06fea9cf33a76df4ddf22a9808e"
    }
  }
]